Redian新闻
>
OPTR发生什么了
avatar
OPTR发生什么了# Stock
Y*o
1
没有新闻暴涨
avatar
v*m
2
可能被收购。
10:02 AM Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that
the antibiotics maker has attracted takeover interest from GlaxoSmithKline
(GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas
. Optimer hopes to fetch up to $1B in an auction, well above its market cap
of $660M. The company has one drug on the market, Dificid, which is used to
treat intestinal infections in hospitalized patients.

【在 Y*******o 的大作中提到】
: 没有新闻暴涨
avatar
Y*o
3
o

that
GlaxoSmithKline
Astellas
cap
to

【在 v**********m 的大作中提到】
: 可能被收购。
: 10:02 AM Optimer Pharmaceuticals (OPTR) surges 18.1% following a report that
: the antibiotics maker has attracted takeover interest from GlaxoSmithKline
: (GSK), AstraZeneca (AZN), Cubist Pharmaceuticals (CBST) and Japan's Astellas
: . Optimer hopes to fetch up to $1B in an auction, well above its market cap
: of $660M. The company has one drug on the market, Dificid, which is used to
: treat intestinal infections in hospitalized patients.

相关阅读
logo
联系我们隐私协议©2024 redian.news
Redian新闻
Redian.news刊载任何文章,不代表同意其说法或描述,仅为提供更多信息,也不构成任何建议。文章信息的合法性及真实性由其作者负责,与Redian.news及其运营公司无关。欢迎投稿,如发现稿件侵权,或作者不愿在本网发表文章,请版权拥有者通知本网处理。